Filgrastim - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
Product details |
Supply Impact Dates |
Further Details |
NEUPOGEN filgrastim (rbe) 300 microgram/0.5mL injection syringe AUST R: 53580Active ingredients:
Filgrastim
Dosage form: Injection, solution
Sponsor: Amgen Australia Pty Ltd
Phone: 1800 803 638
|
Deletion from market:
01 Apr 2024
|
Shortage status: Discontinued
Availability: Reduction in supply until supply is exhausted
Reason: Commercial Changes / Commercial viability
Management action: Alternative generic products are available.
|
NEUPOGEN filgrastim (rbe) 300 microgram/1mL injection vial AUST R: 53579Active ingredients:
Filgrastim
Dosage form: Injection, solution
Sponsor: Amgen Australia Pty Ltd
Phone: 1800 803 638
|
Deletion from market:
15 Feb 2024
|
Shortage status: Discontinued
Availability: Unavailable
Reason: Commercial Changes / Commercial viability
Management action: Alternative generic products are available.
|
NEUPOGEN filgrastim (rbe) 480 microgram/0.5mL injection syringe AUST R: 53581Active ingredients:
Filgrastim
Dosage form: Injection, solution
Sponsor: Amgen Australia Pty Ltd
Phone: 1800 803 638
|
Deletion from market:
01 Apr 2024
|
Shortage status: Discontinued
Availability: Reduction in supply until supply is exhausted
Reason: Commercial Changes / Commercial viability
Management action: Alternative generic products are available.
|
NEUPOGEN filgrastim (rbe) 480 microgram/1.6mL injection vial AUST R: 53577Active ingredients:
Filgrastim
Dosage form: Injection, solution
Sponsor: Amgen Australia Pty Ltd
Phone: 1800 803 638
|
Deletion from market:
01 Oct 2023
|
Shortage status: Discontinued
Availability: Unavailable
Reason: Commercial Changes / Commercial viability
Management action: Alternative generic products are available.
|